The Chinese government has conveyed its concern over Foxconn Technology Group (富士康科技集團) billionaire Terry Gou’s (郭台銘) plan to expand the Apple Inc assembler’s operations in the US after US president-elect Donald Trump takes office, people familiar with the matter said.
A high-ranking Chinese official expressed Beijing’s concerns directly to Gou, the people said, asking not to be identified because the conversation was private.
The Taiwanese billionaire told the senior bureaucrat he would not withdraw capital from China.
Photo: Cho I-chun, Taipei Times
The US investment plan has not been finalized and is dependent on the policies of the incoming administration, Gou said, according to the people.
China is pivotal to Foxconn’s massive electronics assembly operation, which cranks out more iPhones and iPads than any other in the world.
One of China’s largest employers, Foxconn has said it is in preliminary discussions to broaden its investment in the US, without elaborating.
Trump has often articulated his vision of bringing manufacturing jobs back to the US from China, which became the world’s factory floor thanks to cheap labor and central policy support, and he has singled out Apple Inc in the past.
A potential strategic shift by Foxconn unnerves Chinese authorities because the company employs about 1 million workers across the nation. Major factory job cuts have been known to trigger protests in the past, even as maintaining social stability remains among the top priorities of the Chinese Communist Party.
“Gou wants officials to know that he still sees China as a market of greatest importance,” Beijing-based Counterpoint research director James Yan said. “Foxconn very much relies on China for both assembly and consumer businesses and its suppliers are also in Asian countries. That is not going to change at least in the next five years.”
Foxconn announced the potential expansion hours after a pledge from Softbank Group Corp’s Masayoshi Son to invest US$50 billion in the US and create 50,000 jobs.
A document Son held up for reporters after a meeting last month with the US president-elect included the words “Foxconn” and “$7 billion” alongside Softbank’s numbers.
It remains unclear how Softbank and Foxconn might be working together, or what sort of promises might have been made to Trump.
Gou told the Chinese official he was invited to Trump’s inauguration on Friday, but did not plan to attend, according to the people familiar with the matter.
Foxconn operates factories in Chinese cities including Zhengzhou, Shenzhen, Taiyuan and Wuhan, but rising wages and persistent worker shortages are prompting electronics manufacturers to look elsewhere.
Lenovo Group Ltd (聯想) and Oppo Electronics Corp (歐珀) are among those that have set up facilities in Southeast Asia, for instance.
Foxconn itself has been increasing its use of robots to reduce its reliance on migrant labor and studying plans to increase its footprint in India.
Any shift back to the US might involve Apple, which accounts for about half of Hon Hai’s revenue.
However, Apple chief executive officer Tim Cook in 2015 told 60 Minutes that the US simply lacks enough skilled workers in advanced manufacturing.
Then there is cost. The components of an entry-level iPhone 7, which sells for US$649, cost US$224.80, according to research firm IHS Inc. Assembling those parts into a finished product, mostly in China, costs about US$10, Syracuse University professor Jason Dedrick has estimated. Doing that work in the US would add US$30 to US$40, he said.
However, Foxconn’s rivals are reportedly open to the possibility.
Pegatron Corp (和碩), another major assembler of Apple products, can expand its US capacity three to five-fold if necessary, Pegatron chairman Tung Tzu-hsien (童子賢) was cited as saying on Sunday.
PRIORITY GROUPS: A line of people were waiting at the Good Liver Clinic, apparently to get shots, while the CECC announced more priority groups for jabs The Taipei-based Good Liver Clinic is to be fined NT$2 million (US$72,028) after giving free COVID-19 vaccine shots to people not in groups eligible to receive them, Taipei Deputy Mayor Vivian Huang (黃珊珊) said yesterday. The Zhongshan District (中山)-based clinic was removed from the city’s list of vaccination venues and health officials would be investigated for giving 1,113 doses to the clinic, Huang told an afternoon news conference at Taipei City Hall. The Chinese-language Liberty Times (the Taipei Times’ sister paper) on Tuesday in an exclusive story citing an anonymous tip reported that a Taipei clinic was doling out unused vaccines. People in
PHASE 2: The firm’s CEO said that the results were good and the experimental vaccine safe, but added that hoped-for phase 3 trials would be expensive Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported positive results from an interim analysis of phase 2 trials for its COVID-19 vaccine, saying that the vaccine demonstrated high seroconversion rates and geometric mean titer (GMT) figures. A seroconversion rate is the percentage of participants in a trial displaying virus-specific immune memory after being given a vaccine, while the GMT measures the level of neutralizing antibody response, Medigen said. The experimental vaccine has a seroconversion rate of 99.8 percent and its GMT was 662 among the participants aged 20 to 89, while the gauges rose to 99.9 percent and 733 respectively in participants aged
ROLLING OUT DOSES: The expansion aims to speed up Taiwan’s vaccination drive by making more Moderna jabs available to workers at hospitals, the CECC said The Central Epidemic Command Center (CECC) yesterday expanded the eligibility for the Moderna COVID-19 vaccine to all healthcare workers and non-healthcare workers in the highest vaccine priority group. The center said that 75,000 doses of the vaccine — half of the first batch Taiwan has received — were on Wednesday distributed to hospitals across the nation with specialized COVID-19 rooms, negative pressure wards and testing services. Thus far, they had only been offered to frontline healthcare workers and non-healthcare workers at the designated hospitals, it said. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that the eligibility was
NUMBERS HAVE FALLEN: Minister of Health and Welfare Chen Shih-chung said there are good signs, but ‘we cannot afford to let our guard down now’ The Central Epidemic Command Center (CECC) yesterday reported 219 new locally transmitted COVID-19 infections and 22 deaths. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that the 219 local infections — 117 male and 102 female — were aged from under five to over 100 years old, and they began having symptoms between May 22 and Monday. New Taipei City reported 123 cases, followed by Taipei with 54, Miaoli County with 16, Taoyuan with 13, Keelung with eight, Changhua County with two, and one each in Hsinchu City, Taichung and Tainan. The 22 deaths were 15 men and